WHO advises against obesity drugs for younger children

RegulatoryGLP-1 drugsNegative

AI Analysis

Summary

The World Health Organization recommended against using GLP-1 drugs for children under 10 with obesity and advised their use in adolescents only after lifestyle interventions fail.

Outcome Details

WHO recommended against GLP-1 drugs for children under 10 with obesity; recommended use in adolescents ages 10-19 only after supervised lifestyle program fails

Importance:5/10

Sentiment:

-0.30

GLP-1obesitypediatricregulatoryWHO

Read the original article

Published by Endpoints News on October 7, 2026 6:00 PM

Read Original